ClotCare: Blood Clots, Stroke, Heart Attack
Wednesday, October 18, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

INR Self Testing: Opportunity to comment on a petition to expand Medicare coverage of self-testing - 6/26/2007 to 7/26/2007

Henry I. Bussey, Pharm.D., FCCP, FAHA
June, 2007

As you may know, Medicare covers the use of a fingerstick device for INR self-testing only for mechanical heart valve patients. The three US companies that market an INR self-testing device have successfully petitioned Medicare to consider expanding coverage to include, among other patient groups, those patients with atrial fibrillation (A fib) or deep vein thrombosis (DVT). Medicare is currently accepting public comment on this proposal. Anyone is welcome to comment; you do not have to be a healthcare professional. If you would like to share your views on this issue with Medicare, you can read more about this petition at https://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=209. To submit your comments, go to https://www.cms.hhs.gov/mcd/
public_comment.asp?nca_id=209&basketitem=nca%3A00087R%3A209%3AProthrombin+Time+%28INR%29+Monitor+for+Home+Anticoagulation+Management%3AOpen%3A1st+Recon%3A1

Recent information has suggested that improving INR control above 80% time in-range may result in a 50% or more reduction in stroke, heart attack, death, and major bleeding in A. Fib. patients (http://www.clotcare.com/clotcare/improveinrcontrol.aspx). A similar reduction in stroke and major hemorrhage may also be achieved in TIA patients; and some authorities have suggested that such improved anticoagulation may be achieved with frequent self-testing and expert management (http://www.clotcare.com/clotcare/aspirinfortia.aspx).

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

World Thrombosis Day - Oct. 13, 2017

Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future?

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Wednesday, October 18, 2017